Korean Journal of Pediatrics 2004;47(12):1262-1265.
Published online December 15, 2004.
Treatment of Immue Thrombocytopenic Purpura in Childhood
Hwang Min Kim
Department of Pediatrics, Yonsei University Wonju College of Medicine, Wonju, Korea
혈소판 감소성 자반증의 치료
김황민
연세대학교 원주의과대학 소아과학교실
Abstract
Childhood immune thrombocytopenic purpura(ITP) is a typically benign self-limiting bleeding disorder of not fully known autoimmune etiology. Chronic ITP, which is defined by duration of more than 6 months, occurs in approximately 20% of children. Neither the risk of bleeding nor the type of disease, acute or chronic, can be predicted at initial presentation. The indication of treatment, choice of treatment in various clinical conditions are still controversial. In this review, we tried to summarize the indication, mechanism and application of various kinds of treatments in childhood ITP.
Key Words: Immune thrombocytopenic purpura, Childhood, Treatment


METRICS Graph View
  • 2,631 View
  • 61 Download


Close layer
prev next